MUC5AC and cystic fibrosis: As treatments have improved and lifespans of CF patients have increased, there has been a concomitant rise in the number of patients with GI mucin complications of the small intestine including distal intestinal obstruction syndrome and small intestinal bacterial overgrowth (SIBO) [29].